Refine
Has Fulltext
- yes (33)
Year of publication
Document Type
Keywords
- Immunologie (3)
- AC Stark effect (1)
- ADHD (1)
- ALS treatment (1)
- Alien limb syndrome (1)
- Alzheimers disease (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Anarchic limb syndrome (1)
- Berry phase (1)
- Bipolar disorder (1)
- Bloch oscillations (1)
- Bose gas (1)
- Bose-Fermi (1)
- Bragg-reflection waveguide (1)
- Brain trauma (1)
- CHIP (1)
- Corticobasal syndrome (1)
- Depression (1)
- Diagnosis prediction (1)
- EBM (1)
- Entanglement (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- Fermi liquid (1)
- Frühkindlicher Hirnschaden (1)
- GAAS (1)
- GRN (1)
- Gemeindepsychiatrie (1)
- HBO (1)
- Hirninfarkt (1)
- Human behaviour (1)
- Information (1)
- Jaynes-Cummings ladder (1)
- Kausalmodell (1)
- Klinische Psychiatrie (1)
- Kontusion (1)
- LISREL (1)
- Leukoaraiose (1)
- Leukoaraiosis (1)
- Längsschnittuntersuchung (1)
- Maintenance treatment (1)
- Malignant melanoma (1)
- Mania (1)
- PUMP (1)
- Parametric down-conversion (1)
- Parkinson's disease (1)
- Perinatal brain damage (1)
- Personalized medicine (1)
- Pfadanalyse (1)
- Polarity index (1)
- Poststroke depression (1)
- Predominant polarity (1)
- Prognostic markers (1)
- Psychiatric disorders (1)
- Psychiatrie (1)
- Psychologie (1)
- Secondary affective disorder (1)
- Skin cancer screening (1)
- Stage distribution (1)
- Support vector machine (1)
- Survival analysis (1)
- TNM staging (1)
- Varianzanalyse (1)
- affective disorders (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anxiety (1)
- aphasia (1)
- applied physics (1)
- assessment of cognitive disorders/dementia (1)
- assistive devices (1)
- astroglia (1)
- beta oscillations (1)
- birth cohort (1)
- blood-brain-barrier (1)
- caregiver burden (1)
- childhood asthma (1)
- chromosome 11Q13 (1)
- cognitive neuropsychology in dementia (1)
- coherence (1)
- coherent spectroscopy (1)
- colorectal cancer (1)
- decreasing autonomy (1)
- deep brain stimulation (1)
- dementia (1)
- demyelination (1)
- depression (1)
- dermatitis (1)
- diabetes (1)
- diabolical points (1)
- dialysis (1)
- dot (1)
- dressed states (1)
- epidemiology (1)
- epitope specificity (1)
- erythropoietin (1)
- exciton-polariton (1)
- exciton‐polaritons (1)
- experimental stroke (1)
- families (1)
- filaggrin mutations (1)
- focal cerebral-ischemia (1)
- food allergy (1)
- frontotemporal dementia (1)
- frontotemporal lobar degeneration (1)
- functional status (1)
- gain (1)
- genome-wide association (1)
- genomewide association (1)
- group refractive index (1)
- hay fever (1)
- health-related quality of life (1)
- health-related quality of life (HRQoL) (1)
- hiPSC (1)
- iPSC (1)
- illness-death model (1)
- inflammatory mechanisms (1)
- informal caregiving (1)
- interval timing (1)
- juvenile myoclonic epilepsy (1)
- length scale (1)
- light (1)
- light-matter coupling (1)
- light–matter interaction (1)
- linkage (1)
- liver metastases (1)
- liver oligometastases (1)
- lung metastases (1)
- macrophages (1)
- magnetic fields (1)
- materials for optics (1)
- mental disorders (1)
- microcavity (1)
- microglia (1)
- mononuclear phagocytes (1)
- mutation (1)
- myelin (1)
- nanoscience and technology (1)
- oligo-recurrence (1)
- oligometastases (1)
- oncology (1)
- optical physics (1)
- optics and photonics (1)
- organische affektive Störungen (1)
- oscillations (1)
- outcome (1)
- people (1)
- peripheral nervous system (1)
- phasematching (1)
- photon (1)
- physical sciences (1)
- polariton condensation (1)
- psychological support (1)
- quality of life (QoL) (1)
- quantum billiard (1)
- quantum dots (1)
- resonance (1)
- risk (1)
- risk factors (1)
- risk genes (1)
- semiconductor lasers (1)
- semiconductors (1)
- socioeconomic status (1)
- spectral interferometry (1)
- spectroscopy (1)
- stem cells (1)
- stereotactic body radiation therapy (1)
- stereotactic body radiotherapy (1)
- subthalamic nucleus (1)
- symptom-specific treatment (1)
- sync-oligometastases (1)
- system (1)
- tPA (1)
- treated metastases control (1)
- tumor control probability (1)
- tumor-necrosis-factor (1)
- ultrashort time (1)
- volumetric MRI (1)
- waveguides (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Physikalisches Institut (9)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (7)
- Institut für Virologie und Immunbiologie (3)
- Neurologische Klinik und Poliklinik (3)
- Institut für Klinische Epidemiologie und Biometrie (2)
- Institut für Psychologie (bis Sept. 2007) (2)
- Klinik und Poliklinik für Strahlentherapie (2)
- Abteilung für Forensische Psychiatrie (1)
- Fakultät für Physik und Astronomie (1)
- Institut für Physikalische und Theoretische Chemie (1)
Sonstige beteiligte Institutionen
Three spectroscopic techniques are presented that provide simultaneous spatial and temporal resolution: modified confocal microscopy with heterodyne detection, space-time-resolved spectroscopy using coherent control concepts, and coherent two-dimensional nano-spectroscopy. Latest experimental results are discussed.
Background
The aim of this analysis was to model the effect of local control (LC) on overall survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung metastases from colorectal cancer.
Methods
The analysis is based on pooled data from two retrospective SBRT databases for pulmonary and hepatic metastases from 27 centers from Germany and Switzerland. Only patients with metastases from colorectal cancer were considered to avoid histology as a confounding factor. An illness-death model was employed to model the relationship between LC and OS.
Results
Three hundred eighty-eight patients with 500 metastatic lesions (lung n = 209, liver n = 291) were included and analyzed. Median follow-up time for local recurrence assessment was 12.1 months. Ninety-nine patients with 112 lesions experienced local failure. Seventy-one of these patients died after local failure. Median survival time was 27.9 months in all patients and 25.4 months versus 30.6 months in patients with and without local failure after SBRT. The baseline risk of death after local failure exceeds the baseline risk of death without local failure at 10 months indicating better survival with LC.
Conclusion
In CRC patients with lung or liver metastases, our findings suggest improved long-term OS by achieving metastatic disease control using SBRT in patients with a projected OS estimate of > 12 months.
Cortex-basal ganglia circuits participate in motor timing and temporal perception, and are important for the dynamic configuration of sensorimotor networks in response to exogenous demands. In Parkinson's disease (PD) patients, rhythmic auditory stimulation (RAS) induces motor performance benefits. Hitherto, little is known concerning contributions of the basal ganglia to sensory facilitation and cortical responses to RAS in PD. Therefore, we conducted an EEG study in 12 PD patients before and after surgery for subthalamic nucleus deep brain stimulation (STN-DBS) and in 12 age-matched controls. Here we investigated the effects of levodopa and STN-DBS on resting-state EEG and on the cortical-response profile to slow and fast RAS in a passive-listening paradigm focusing on beta-band oscillations, which are important for auditory–motor coupling. The beta-modulation profile to RAS in healthy participants was characterized by local peaks preceding and following auditory stimuli. In PD patients RAS failed to induce pre-stimulus beta increases. The absence of pre-stimulus beta-band modulation may contribute to impaired rhythm perception in PD. Moreover, post-stimulus beta-band responses were highly abnormal during fast RAS in PD patients. Treatment with levodopa and STN-DBS reinstated a post-stimulus beta-modulation profile similar to controls, while STN-DBS reduced beta-band power in the resting-state. The treatment-sensitivity of beta oscillations suggests that STN-DBS may specifically improve timekeeping functions of cortical beta oscillations during fast auditory pacing.
Planar microcavities with distributed Bragg reflectors (DBRs) host, besides confined optical modes, also mechanical resonances due to stop bands in the phonon dispersion relation of the DBRs. These resonances have frequencies in the 10- to 100-GHz range, depending on the resonator's optical wavelength, with quality factors exceeding 1,000. The interaction of photons and phonons in such optomechanical systems can be drastically enhanced, opening a new route towards the manipulation of light. Here we implemented active semiconducting layers into the microcavity to obtain a vertical-cavity surface-emitting laser (VCSEL). Thereby, three resonant excitations--photons, phonons and electrons--can interact strongly with each other providing modulation of the VCSEL laser emission: a picosecond strain pulse injected into the VCSEL excites long-living mechanical resonances therein. As a result, modulation of the lasing intensity at frequencies up to 40 GHz is observed. From these findings, prospective applications of active optomechanical resonators integrated into nanophotonic circuits may emerge.
We report on electrically pumped quantum dot-microlasers in the presence of polarized self-feedback. The high-\(\beta\) microlasers show two orthogonal, linearly polarized emission modes which are coupled via the common gain medium. This coupling is explained in terms of gain competition between the two lasing modes and leads to distinct differences in their input-output characteristics. By applying polarized self-feedback via an external mirror, we are able to control the laser characteristics of the emission modes in terms of the output power, the coherence time and the photon statistics. We find that linearly polarized self-feedback stabilizes the lasing of a given mode, while cross-polarized feedback between the two modes reduces strongly the intensity of the other emission mode showing particular high-intensity fluctuations and even super-thermal values of the photon autocorrelation function \(g^{(2)} (\tau)\) at zero delay. Measurements of \(g^{(2)} (\tau)\) under external feedback also allow us to detect revival peaks associated with the round trip time of the external cavity. Analyzing the damping and shape of the \(g^{(2)} (\tau)\) revival peaks by a phenomenological model provides us insight into the underlying physics such as the effective exciton lifetime and gain characteristics of the quantum dots in the active region of these microlasers.
Eczema often precedes the development of asthma in a disease course called the 'atopic march'. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P = 2.1 x 10(-8)) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P = 5.3 x 10(-9)). Additional susceptibility loci identified at genome-wide significance are FLG (1q21.3), IL4/KIF3A (5q31.1), AP5B1/OVOL1 (11q13.1), C11orf30/LRRC32 (11q13.5) and IKZF3 (17q21). We show that predominantly eczema loci increase the risk for the atopic march. Our findings suggest that eczema may play an important role in the development of asthma after eczema.
Microcavity exciton polaritons are promising candidates to build a new generation of highly nonlinear and integrated optoelectronic devices. Such devices range from novel coherent light emitters to reconfigurable potential landscapes for electro-optical polariton-lattice based quantum simulators as well as building blocks of optical logic architectures. Especially for the latter, the strongly interacting nature of the light-matter hybrid particles has been used to facilitate fast and efficient switching of light by light, something which is very hard to achieve with weakly interacting photons. We demonstrate here that polariton transistor switches can be fully integrated in electro-optical schemes by implementing a one-dimensional polariton channel which is operated by an electrical gate rather than by a control laser beam. The operation of the device, which is the polariton equivalent to a field-effect transistor, relies on combining electro-optical potential landscape engineering with local exciton ionization to control the scattering dynamics underneath the gate. We furthermore demonstrate that our device has a region of negative differential resistance and features a completely new way to create bistable behavior.
Background
The intent of this pooled analysis as part of the German society for radiation oncology (DEGRO) stereotactic body radiotherapy (SBRT) initiative was to analyze the patterns of care of SBRT for liver oligometastases and to derive factors influencing treated metastases control and overall survival in a large patient cohort.
Methods
From 17 German and Swiss centers, data on all patients treated for liver oligometastases with SBRT since its introduction in 1997 has been collected and entered into a centralized database. In addition to patient and tumor characteristics, data on immobilization, image guidance and motion management as well as dose prescription and fractionation has been gathered. Besides dose response and survival statistics, time trends of the aforementioned variables have been investigated.
Results
In total, 474 patients with 623 liver oligometastases (median 1 lesion/patient; range 1–4) have been collected from 1997 until 2015. Predominant histologies were colorectal cancer (n = 213 pts.; 300 lesions) and breast cancer (n = 57; 81 lesions). All centers employed an SBRT specific setup. Initially, stereotactic coordinates and CT simulation were used for treatment set-up (55%), but eventually were replaced by CBCT guidance (28%) or more recently robotic tracking (17%). High variance in fraction (fx) number (median 1 fx; range 1–13) and dose per fraction (median: 18.5 Gy; range 3–37.5 Gy) was observed, although median BED remained consistently high after an initial learning curve. Median follow-up time was 15 months; median overall survival after SBRT was 24 months. One- and 2-year treated metastases control rate of treated lesions was 77% and 64%; if maximum isocenter biological equivalent dose (BED) was greater than 150 Gy EQD2Gy, it increased to 83% and 70%, respectively. Besides radiation dose colorectal and breast histology and motion management methods were associated with improved treated metastases control.
Conclusion
After an initial learning curve with regards to total cumulative doses, consistently high biologically effective doses have been employed translating into high local tumor control at 1 and 2 years. The true impact of histology and motion management method on treated metastases control deserve deeper analysis. Overall survival is mainly influenced by histology and metastatic tumor burden.
Basing on the assumption that frontotemporal lobar degeneration (FTLD), schizophrenia and bipolar disorder (BPD) might share common aetiological mechanisms, we analyzed genetic variation in the FTLD risk gene progranulin (GRN) in a German population of patients with schizophrenia (n=271) or BPD (n=237) as compared with 574 age-, gender-and ethnicity-matched controls. Furthermore, we measured plasma progranulin levels in 26 German BPD patients as well as in 61 Italian BPD patients and 29 matched controls. A significantly decreased allelic frequency of the minor versus the wild-type allele was observed for rs2879096 (23.2 versus 34.2%, P<0.001, OR: 0.63, 95% CI: 0.49-0.80), rs4792938 (30.7 versus 39.7%, P=0.005, OR: 0.70, 95% CI: 0.55-0.89) and rs5848 (30.3 versus 36.8, P=0.007, OR: 0.71, 95% CI: 0.56-0.91). Mean +/- SEM progranulin plasma levels were significantly decreased in BPD patients, either Germans or Italians, as compared with controls (89.69 +/- 3.97 and 116.14 +/- 5.80 ng/ml, respectively, versus 180.81 +/- 18.39 ng/ml P<0.001) and were not correlated with age. In conclusion, GRN variability decreases the risk to develop BPD and schizophrenia, and progranulin plasma levels are significantly lower in BPD patients than in controls. Nevertheless, a larger replication analysis would be needed to confirm these preliminary results.
Human immunodeficiency virus (HIV-1) infection in the human brain Ieads to characteristic neuropathological changes, which may result indirectly from interactions of the envelope glycoprotein gp 120 with neurons and/or glial cells. We therefore investigated the binding of recombinant gp120 (rgp120) to human neural cells and its effect on int~acellular.s.ignallin~. Herewe pre~ent evidence that rgp120, besides binding to galactocerebroside or galactosyl-sulfatlde, spec1f1cally bmds to a protem receptor of a relative molecular mass of approximately 180,000 Da (180 kDa) pre~ent. on the CD4-negative glioma cells D-54, but not on Molt4 T lymphocytes. Binding of rgp120 to this receptor rap1dly 1nduced a tyrosine-specific protein kinase activity leading to tyrosine phosphorylation of 130- and 115-kDa p~oteins. The c~ncentration of intracellular calciumwas not affected by rgp120 in these cells. Our data suggest a novel Signal transduc1ng HIV-1 gp120 receptor on CD4-negative glial cells, which may contribute to the neuropathological changes observed in HIV-1-infected brains.